Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology
China Biotechnology  2016, Vol. 36 Issue (9): 119-125    DOI: 10.13523/j.cb.20160915
    
The Analysis of Chinese Blood Biologicals Industry
LI Min
Institute of Science and Technology Strategy, Jiangxi Academy of Sciences, Nanchang 330096, China
Download: HTML   PDF(802KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Blood products are those biologicals derived from plasma or obtained by recombinant technologies. The regular blood biologicals which be applied in clinic at present mainly contain albumin, immunoglobulins and coagulation factors. A briefly analysis about the blood biologicals industry in China, covering the development process, the current status of market, the main technology, the key domestic enterprises and the likely trends in the future of blood biologicals industry were given.

Key words： Current status of market      Main technology      Domestic enterprise      Blood biological      Development process      Trend in the future     
Received: 28 March 2016      Published: 25 September 2016
ZTFLH:  Q51  
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
Cite this article:

LI Min. The Analysis of Chinese Blood Biologicals Industry. China Biotechnology, 2016, 36(9): 119-125.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20160915     OR     https://manu60.magtech.com.cn/biotech/Y2016/V36/I9/119

[1] 王卓, 赵雄, 吕茂民,等. 血液制品的现状与展望. 生物工程学报, 2011, 27(5):730-746. Wang ZH, Zhao X, Lv M M, et al. Current status and trends in blood biologicals. Chinese Journal of Biotechnology, 2011, 27(5):730-746.
[2] 杨生, 钟雪峰. 血液制品市场现状. 中国生化药物杂志, 2008, 29(6):430-432. Yang S H, Zhong X F. Current marketing situation for blood products. Chinese Journal of Biochemical Pharmaceutics, 2008, 29(6):430-432.
[3] 章金刚. 血液制品及其在伤病救治中的应用. 军事医学, 2015, 39(3):161-164. Zhang J G. Blood products and its applications for the treatment of military trauma and diseases. Military Medical Sciences, 2015, 39(3):161-164.
[4] 段红杰, 柴家科, 邓虎平. 人血白蛋白的功能及其在危重病治疗中的应用.解放军医学杂志, 2012, 37(10):926-929. Duan H J, Chai J K, Deng H P. Function of human serum albumin and its application in therapy of critical illness. Medical Journal of Chinese People's Liberation Army, 2012, 37(10):926-929.
[5] 林孝发,王妍.层析技术在血液制品分离纯化中应用的探讨.微生物学免疫学进展,2015,1:73-78. Lin X F, Wang Y. Chromatography technique in separation and purification of blood products. Progress in Microbiology and Immunology, 2015, 43(1):73-78.
[6] 喇文军,王妍,周靖,等.一步柱层析纯化血浆分离多种血液制品组分.中国生物制品学杂志,2015,2:194-198. La W J, Wang Y, Zhou J, et al. Separation of various plasma components by purification with one step column chromatography. Chinese Journal of Biologicals, 2015, 28(2):194-198.
[7] 刘仲敏,张中平.生物制品产业发展研究报告//河南省化学学会、河南省生物工程学会、河南省食品科学技术学会、河南省化工学会,第三届河南省化学、化工与生物、食品学术研讨会论文集.河南,2015:8-25. Liu Z M, Zhang Z P. Research Report on The Development of Biological Products Industry//The Third Symposium on Chemistry, Chemical Industry, Biology and Food in Henan Province. Henan:China Acedemic Journal Electronic Publishing House, 2015:8-25.
[8] 宋清爽,吴恩应,张运佳,等.血液制品病毒灭活及去除工艺进展.生物技术通讯,2012,4:627-630. Song Q S, Wu E Y, Zhang Y J, et al. Advance in virus inactivation and removal processes of blood products. Letters in Biotechnology, 2012, 23(4):627-630.
[9] 迟妍妍,王斐,张惠,等.血液制品病毒灭活/去除方法概述.药学研究,2014,4:227-229. Chi Y Y, Wang F, Zhang H, et al. Summary of viral inactivation/removal methods in plasma-derived products. Journal of Pharmaceutical Research, 2014, 33(4):227-229.
[10] 赵洪平. 我国血液制品行业的现状与前景. 实践与探索, 2011, 12:272. Zhao H P. Current status and prospect of blood products industry in China. Intelligence, 2011, 12:272.
[1] YUAN Bo,WANG Jie-wen,KANG Guang-bo,HUANG He. Research Progress and Application of Bispecific Nanobody[J]. China Biotechnology, 2021, 41(2/3): 78-88.
[2] YANG Xiao-ying,LI Meng,ZHAO Wei,TANG Min,ZHANG Zhi-qian. Preparation and Preliminary Characterization of Anti-α2δ1/CD3 Bispecific Antibody[J]. China Biotechnology, 2020, 40(7): 9-14.
[3] CHU Yu-qi,LU Fei-fei,LIU Yang,HE Fang,WANG Da-zhuang,CHEN Li-jiang. Interaction between Protein Corona and Nanoparticles[J]. China Biotechnology, 2020, 40(4): 78-83.
[4] TANG Xin,MAO Xin-fang,MA Bin-yun,GOU Ping. Antimicrobial Peptides: Current Status and Future Challenges[J]. China Biotechnology, 2019, 39(8): 86-94.
[5] Er-shu XUE,Qian-qian SONG,Kai-ren TIAN,Jian-jun QIAO,Cai-yin QINGGELE. Research Progress in the Biosynthesis and Regulation of D-amino Acids in Bacterial[J]. China Biotechnology, 2019, 39(4): 106-113.
[6] Qian GAO,Hong JIANG,Mao YE,Wen-juan GUO. Current Status and Trend of R&D of Monoclonal Antibodies[J]. China Biotechnology, 2019, 39(3): 111-119.
[7] FANG Yuan,XU Guang-xian,WANG Xian,WANG Hong-xia,PAN Jun-fei. Construction of Camelid Natural Nanobody Phage Display Library and Screening for Anti-GDH Nanobody[J]. China Biotechnology, 2018, 38(12): 49-56.
[8] Jia-ao GE,Chang LIU,Jian-gang GONG,Yan-qin LIU. Research Progress of Antibacterial Cyclopeptides[J]. China Biotechnology, 2018, 38(11): 76-83.
[9] Ming-ying LI,Ren-jun WANG,Fun ZHANG,Yan CHI. The Prokaryotic Expression and Activity Analysis of the Fifth Domain of β2GPⅠ and Its Mutants or Short Peptide Fragments[J]. China Biotechnology, 2018, 38(8): 1-9.
[10] Xin GAO,Pan-jian WEI,Zhuo-hong YAN,Ling YI,Xiao-jue WANG,Bin YANG,Hong-tao ZHANG. Cloning and Expression of Single Chain Antibody Against Human EGFR[J]. China Biotechnology, 2018, 38(5): 73-78.
[11] Kai DU,Zhuo-ling ZHANG,Ting-hua LI,Wei RAO. The Research Progress of Antibody Immobilization[J]. China Biotechnology, 2018, 38(4): 78-89.
[12] MENG Kun, HE Qing-yu, WANG Tong, LU Shao-hua. The Study of Protein-protein Interactions Using a Flow Cytometry-based FRET Technology in Living Cells[J]. China Biotechnology, 2017, 37(5): 45-51.
[13] XU Yun-qiao, LI Ting-ting, WU Cai-e, FAN Gong-jian, LI Tong. Research Progress on the Methods of Deglycosylation of Glycoproteins[J]. China Biotechnology, 2017, 37(5): 97-106.
[14] CHEN Rong, YANG Fan, CHENG Xi-yao, SU Zheng-ding. Progress in Designing of Inhibitors Mimicking α-Helical Peptide[J]. China Biotechnology, 2017, 37(4): 89-97.
[15] ZHAO Shuang, LIU Liu, WU Lin-huan, MA Jun-cai. Research and Development Trend of the Technology on Corynebacterium glutamicum[J]. China Biotechnology, 2016, 36(9): 101-109.
主管：中国科学院 　主办：中国科学院文献情报中心 　中国生物技术发展中心 　中国生物工程学会